Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Setsuko K Chambers

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
Molecular and Cellular Biology|October 27, 2010
Posttranscriptional suppression of proto-oncogene c-fms expression by vigilin in breast cancerHo-Hyung Woo, Xiaofang Yi, Tiffany Lamb, et al.
Molecular Cancer Research : MCR|August 19, 2008
The multifunctional protein glyceraldehyde-3-phosphate dehydrogenase is both regulated and controls colony-stimulating factor-1 messenger RNA stability in ovarian cancerYi Zhou, Xiaofang Yi, Jha'nae B Stoffer, et al.
Neoplasia (New York, N.Y.)|January 30, 2009
Enhanced ovarian cancer tumorigenesis and metastasis by the macrophage colony-stimulating factorEugene P Toy, Masoud Azodi, Nancy L Folk, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 9, 2016
Pilot Clinical Evaluation of a Confocal Microlaparoscope for Ovarian Cancer DetectionMatthew D Risi, Andrew R Rouse, Setsuko K Chambers, et al.
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society|May 23, 2015
Evaluation of a hypoxia regulated gene panel in ovarian cancerAmanda F Baker, Scott W Malm, Ritu Pandey, et al.
Gynecologic Oncology|December 7, 2002
Procollagen-derived biomarkers in malignant ascites of ovarian cancer. Independent prognosticators for progression-free interval and survivalBernadette M Cracchiolo, Hartmut M Hanauske-Abel, Peter E Schwartz, et al.
Familial Cancer|November 27, 2012
An unusual BRCA mutation distribution in a high risk cancer genetics clinicAnna C Nelson-Moseke, Joanne M Jeter, Haiyan Cui, et al.
Magnetic Resonance in Medicine|May 26, 2016
Noninvasive detection of enzyme activity in tumor models of human ovarian cancer using catalyCEST MRISanhita Sinharay, Edward A Randtke, Kyle M Jones, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 7, 2014
Tubal origin of ovarian endometriosisZeng Yuan, Lijie Wang, Yiying Wang, et al.
American Journal of Cancer Research|December 9, 2020
Loss of tubal ciliated cells as a risk for "ovarian" or pelvic serous carcinomaTao Tao, Wanrun Lin, Yan Wang, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
Molecular and Cellular Biology|October 27, 2010
Posttranscriptional suppression of proto-oncogene c-fms expression by vigilin in breast cancerHo-Hyung Woo, Xiaofang Yi, Tiffany Lamb, et al.
Molecular Cancer Research : MCR|August 19, 2008
The multifunctional protein glyceraldehyde-3-phosphate dehydrogenase is both regulated and controls colony-stimulating factor-1 messenger RNA stability in ovarian cancerYi Zhou, Xiaofang Yi, Jha'nae B Stoffer, et al.
Neoplasia (New York, N.Y.)|January 30, 2009
Enhanced ovarian cancer tumorigenesis and metastasis by the macrophage colony-stimulating factorEugene P Toy, Masoud Azodi, Nancy L Folk, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 9, 2016
Pilot Clinical Evaluation of a Confocal Microlaparoscope for Ovarian Cancer DetectionMatthew D Risi, Andrew R Rouse, Setsuko K Chambers, et al.
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society|May 23, 2015
Evaluation of a hypoxia regulated gene panel in ovarian cancerAmanda F Baker, Scott W Malm, Ritu Pandey, et al.
Gynecologic Oncology|December 7, 2002
Procollagen-derived biomarkers in malignant ascites of ovarian cancer. Independent prognosticators for progression-free interval and survivalBernadette M Cracchiolo, Hartmut M Hanauske-Abel, Peter E Schwartz, et al.
Familial Cancer|November 27, 2012
An unusual BRCA mutation distribution in a high risk cancer genetics clinicAnna C Nelson-Moseke, Joanne M Jeter, Haiyan Cui, et al.
Magnetic Resonance in Medicine|May 26, 2016
Noninvasive detection of enzyme activity in tumor models of human ovarian cancer using catalyCEST MRISanhita Sinharay, Edward A Randtke, Kyle M Jones, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 7, 2014
Tubal origin of ovarian endometriosisZeng Yuan, Lijie Wang, Yiying Wang, et al.
American Journal of Cancer Research|December 9, 2020
Loss of tubal ciliated cells as a risk for "ovarian" or pelvic serous carcinomaTao Tao, Wanrun Lin, Yan Wang, et al.
Pageof 7